Skip to main content
Lexeo Therapeutics, Inc. (LXEO)
NASDAQ: LXEO · Real-Time Price · USD
7.44
+0.59 (8.61%)
At close: Mar 9, 2026, 4:00 PM EDT
7.43
-0.01 (-0.13%)
After-hours: Mar 9, 2026, 6:25 PM EDT

Lexeo Therapeutics Revenue

Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
61
Market Cap
543.03M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2024---
Dec 31, 2023---
Dec 31, 2022654.00K-1.00M-60.53%
Dec 31, 20211.66M1.14M219.59%
Dec 31, 2020518.48K--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
REGENXBIO 170.44M
Verastem 30.91M
MeiraGTx Holdings 27.42M
Ocugen 4.41M
YD Bio 510.36K
Allogene Therapeutics 22.00K
Revenue Rankings

LXEO News

More News